Chongfan Technology
News
07
2025
-
06
Luo Yuan/Zeng Zexian's team developed a spatial omics data analysis platform to empower disease mechanism research and drug development
Author:
SOAR is one of the most comprehensive spatial omics databases and analytical platforms known to date, integrating 3461 high-quality samples from 13 species, 42 tissue types, and 19 spatial transcriptomics technologies, and standardized processing through a unified workflow. SOAR not only focuses on data aggregation, but is also an open analytical platform, building standardized data processing workflows and rich data visualization and analysis tools.
In this study, the research team used the SOAR platform to focus on the analysis of cancer spatial omics data, and found that the polarization state of CXCL16⁺/SPP1⁺ macrophages reflects a key feature of the coordination of immune cell polarization in the tumor microenvironment. This finding not only enriches our understanding of tumor immune heterogeneity, but also provides a new perspective for future tumor immunotherapy target screening.
It is worth mentioning that SOAR has successfully integrated spatial omics data with drug target databases to provide users with target discovery and drug screening functions, thereby promoting future precision medicine research and drug development. In the study of ulcerative colitis, SOAR demonstrated its powerful ability in immune-related drug repositioning. Using the SOAR platform, the research team analyzed spatial omics data from healthy controls and ulcerative colitis patients treated with vedolizumab, and revealed the abnormal activation of the JAK-STAT pathway in T cells and myeloid cells (including macrophages and monocytes) in the lesion area. SOAR accurately identified the significant inhibitory effects of JAK inhibitors such as tofacitinib, TG-101348, and niclosamide in immune cells, which is particularly evident in vedolizumab-non-responders where traditional treatment is ineffective. SOAR's drug interference analysis showed that these small molecules can effectively inhibit the expression of various pro-inflammatory cytokines and their receptors (such as IL-2R, CSF1R, TNF, and IL23A), thereby downregulating inflammatory signaling pathways, reducing mucosal immune cell infiltration and epithelial damage. This result not only provides a treatment option with broad-spectrum immunomodulatory capabilities for patients with inflammatory bowel disease, but also provides data support for the design of future combination therapy clinical trials, highlighting the potential of SOAR in analyzing inflammatory mechanisms and promoting the development of immune-related drugs. In addition, by analyzing cancer spatial omics data, SOAR successfully predicted and verified sirolimus and trichostatin A as anti-cancer drug candidates that can target the PI3K/Akt/mTOR pathway to inhibit cancer cell growth and proliferation.
Yiming Li, Yanyi Ding, Saya Dennis, Meghan Hutch, and Jiaqi Zhou are the co-first authors of this paper. Yuan Luo and Ze Xian Zeng are the co-corresponding authors. The release of SOAR provides a solid foundation for future algorithm benchmarking, disease mechanism exploration, target discovery, and drug screening. With further technological advancements, SOAR is expected to become a daily tool for researchers and pharmaceutical developers, promoting the analysis of disease molecular mechanisms and the development of precision treatment strategies.
LATEST NEWS
2025-06-06
Photonic avalanche nanocrystals with >500-order optical nonlinear response
At the forefront of nonlinear optical materials research, photon avalanche (PA), a unique luminescence mechanism occurring in lanthanide-ion-doped systems, exhibits exponential response under continuous laser pumping through an energy positive feedback loop mechanism, thus demonstrating ultra-high-order nonlinear optical behavior far exceeding traditional upconversion processes.
2025-06-05
Ji Xingchen/Su Yikai LPR | 780 nm on-chip integrated high-Q ultra-wideband Fabry-Perot cavity
With the rapid development of applications such as quantum precision measurement, atom manipulation, and narrow linewidth lasers, higher and higher demands are placed on high-performance photonic devices operating in the visible and near-visible wavelength range (especially the 780 nm wavelength corresponding to the rubidium atomic transition).
2025-06-23
Binary optics and metasurface lenses
Bichromatic optics is a subject or an optical technology; the concept of a meta-lens is more inclined to be a device.
2025-06-23
Achromatic diffractive waveguide in AR glasses
AR glasses seem to have developed rapidly in recent years; many believe this is the device most likely to replace mobile phones in the future.
Thank you for visiting the official website of Chongfan Technology. If you have cooperation intentions or suggestions, please contact us through the following methods, and we will reply as soon as possible, thank you!
Address: Room 403, Building 6, Phase III of R&D, No. 36 Xiyong Avenue, High tech Zone, Chongqing, China.
Telephone: +86-13658337211
E-mail: Sales@cfkeji.net
Website: www.cfkeji.net
Mobile Version
